🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 108 of 200 · A–Z by INN

  1. lesinurad

    ZURAMPIC IRONWOOD PHARMACEUTICALS INC

    ORAL FDA: approved · EMA: withdrawn

    M04AB05

  2. letermovir

    PREVYMIS

    ORAL FDA: approved · EMA: approved · PMDA: approved

    J05

  3. letibotulinumtoxina-wlbg

    LETYBO

    FDA: approved

  4. letrozole

    ARX-LETROZOLE Novartis Pharmaceuticals

    ORAL FDA: approved · TGA: approved · NMPA: clinical trials

  5. leucovorin

    NMPA: clinical trials

  6. leucovorin calcium

    LEUCOVORIN CALCIUM Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  7. leuprolide

    NMPA: clinical trials

  8. leuprolide acetate

    LUPANETA PACK Amneal Pharma Europe Ltd

    IMPLANTATION FDA: approved

  9. leuprolide mesylate

    CAMCEVI KIT

    SUBCUTANEOUS FDA: approved

  10. leuprorelin

    ELIGARD 1 MONTH AbbVie

    EMA: approved · TGA: approved

  11. levacetylleucine

    AQNEURSA

    ORAL FDA: approved

  12. levacetylmethadol

    ORLAAM

    EMA: withdrawn

    N02AC

  13. levalbuterol hydrochloride

    LEVALBUTEROL HYDROCHLORIDE Teva Pharma GmbH

    INHALATION FDA: approved

  14. levalbuterol tartrate

    XOPENEX HFA

    INHALATION FDA: approved

  15. levallorphan tartrate

    LORFAN

    INJECTION FDA: approved

  16. levamisole hydrochloride

    ERGAMISOL

    ORAL FDA: approved

  17. levamlodipine maleate

    CONJUPRI

    ORAL FDA: approved

  18. levetiracetam

    APO-LEVETIRACETAM Alphapharm Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    N03AX14

  19. levobetaxolol hydrochloride

    BETAXON

    OPHTHALMIC FDA: approved

  20. levobunolol hydrochloride

    AKBETA

    OPHTHALMIC FDA: approved

  21. levobupivacaine hydrochloride

    CHIROCAINE

    INJECTION FDA: approved

  22. levocabastine hydrochloride

    LIVOSTIN

    OPHTHALMIC FDA: approved

  23. levocarnitine

    LEVOCARNITINE Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  24. levocetirizine dihydrochloride

    LEVOCETIRIZINE DIHYDROCHLORIDE Teva Pharma GmbH

    ORAL FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources